However, CD4/CD8 ratio was significantly lower in the late relapsed multiple myeloma group compared with HDs (0.15 vs. 1.43 ± 0.1, P < 0.005; Fig. 1C). This evidence concerns the gene CD4 and plasma cell myeloma.